BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7422917)

  • 1. [The level of protease inhibitors in experimental acute pancreatitis and after glucagon administration (author's transl)].
    Podkowicz K; Prokopowicz J; Gabryelewicz A
    Przegl Lek; 1980; 37(5):453-6. PubMed ID: 7422917
    [No Abstract]   [Full Text] [Related]  

  • 2. [Glucagon treatment and plasma kininogenesis in acute experimental pancreatitis (author's transl)].
    Gabryelewicz A; Szalaj W; Stasiewicz J; Biedziński T; Moniuszko-Jakoniuk J
    Przegl Lek; 1976; 33(2):307-10. PubMed ID: 1257513
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum antiprotease concentrations in dogs with spontaneous and experimentally induced acute pancreatitis.
    Murtaugh RJ; Jacobs RM
    Am J Vet Res; 1985 Jan; 46(1):80-3. PubMed ID: 2578757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of trypsin and kallikrein (andecalin) on the activity of proteolytic enzymes and their inhibitors in acute experimental pancreatitis].
    Kolenda IuV; Vansovich VE; Vovchuk SV; Levitskiĭ AP
    Vopr Med Khim; 1987; 33(5):122-4. PubMed ID: 3318106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Histochemical studies of lysosomal hydrolases of dog pancreas in the course of acute experimental pancreatitis treated with heparin and glucagon].
    Bajko K
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1977; 21():37-48. PubMed ID: 408912
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of protease inhibitors during acute haemorrhagic pancreatitis. Experimental findings and clinical implications.
    Amundsen E
    Ann Chir Gynaecol Fenn; 1972; 61(5):284-7. PubMed ID: 4539882
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of acute pancreatitis by glucagon. Experimental studies in dogs].
    De Medeiros RR; Leonapdi LS; Comodo H; Fagundes JJ; Mantovani M
    G E N; 1977; 31(3):251-7. PubMed ID: 97132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prospects for the use of protease inhibitors in acute pancreatitis].
    Gostishchev VK; Vladimirov VG; Zhuravlev AG; Vasil'kova ZF; Zalit SV
    Khirurgiia (Mosk); 1983 Jan; (1):66-70. PubMed ID: 6827798
    [No Abstract]   [Full Text] [Related]  

  • 9. [Proteinase inhibiting agents and glucagon in acute pancreatitis (author's transl)].
    Kirsch A; Werner U; Heinze D
    Zentralbl Chir; 1978; 103(5):291-303. PubMed ID: 349961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heparin and glucagon treatment of acute pancreatitis--results (author's transl)].
    Gabryelewicz A; Olszewski S; Szalaj W; Puchalski Z; Stasiewicz J
    Przegl Lek; 1976; 33(2):323-8. PubMed ID: 1257517
    [No Abstract]   [Full Text] [Related]  

  • 11. [Controlled therapeutic trial of aprotinin and glucagon in acute pancreatitis (author's transl)].
    Gauthier A; Gillet M; Di Costanzo J; Camelot G; Maurin P; Sarles H
    Gastroenterol Clin Biol; 1978 Oct; 2(10):777-84. PubMed ID: 365662
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes in the level of inhibitors of pancreatic proteolytic enzymes in pancreatitis in rats].
    Chernoiarova OD
    Patol Fiziol Eksp Ter; 1985; (4):40-3. PubMed ID: 4058937
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of the endolymphatic administration of protease inhibitors on pancreatic morphofunctional activity in acute experimental pancreatitis].
    Penin VA; Petrov VV; Titova GP; Sil'monovich NN; Shepilova ZhI
    Farmakol Toksikol; 1982; 45(5):83-7. PubMed ID: 6183145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute experimental pancreatitis treated with glucagon Histological study (part I).
    Bajko K; Szalaj W
    Mater Med Pol; 1976; 8(4):404-7. PubMed ID: 1027956
    [No Abstract]   [Full Text] [Related]  

  • 15. Protease-antiprotease balance in serum and pancreatic tissue in acute experimental pancreatitis in rats.
    Gabryelewicz A; Kosidło S; Prokopowicz J; Podkowicz K; Andrzejewska A
    Mt Sinai J Med; 1987 Jun; 54(5):384-8. PubMed ID: 3309631
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of acute pancreatitis with glucagon. Experimental studies in dogs].
    de Medeiros RR; Leonardi LS; Comodo H; Machado MC; Fagundes JJ; de Faria JL; Mantovani M
    AMB Rev Assoc Med Bras; 1976 Jun; 22(6):195-8. PubMed ID: 788060
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dynamics of changes in the protease-inhibitory balance in blood plasma of dogs with experimental acute pancreatitis].
    Belova LA; Privalov GV; Bazhenova GE; Shtukaturov MIu; Makarovskiĭ VV; Brekhov EI; Malakhov VN; Ogloblina OG
    Patol Fiziol Eksp Ter; 1991; (1):52-4. PubMed ID: 2057239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Various effects of aprotinin, glucagon, calcitonin and somatostatin in acute pancreatitis. A comparative animal experiment].
    Jost JO; Clemens M; Pütter C; Hunecke U
    Helv Chir Acta; 1983 Mar; 49(6):799-803. PubMed ID: 6190780
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of acute pancreatitis with glucagon].
    Stagnitti F; Gargiulo A
    Minerva Chir; 1979 May; 34(10):799-801. PubMed ID: 471277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of lysosomal hydrolases in the pathogenesis of acute pancreatitis.
    Dlugosz J
    Mater Med Pol; 1974; 6(4):260-70. PubMed ID: 4453149
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.